BENZYLPENICILLOYL POLYLYSINE

BENZYLPENICILLOYL POLYLYSINE was reported 35 times

BENZYLPENICILLOYL POLYLYSINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SKIN TEST NEGATIVE 2 0.0198
1 FALSE NEGATIVE INVESTIGATION RESULT 9 0.0128
2 OVERGROWTH FUNGAL 1 0.0097
3 ALLERGY TEST NEGATIVE 1 0.0064
4 LARYNGEAL OBSTRUCTION 1 0.0055
5 SKIN TEST POSITIVE 4 0.0043
6 ADMINISTRATION SITE ERYTHEMA 1 0.0035
7 TYPE III IMMUNE COMPLEX MEDIATED REACTION 1 0.0018
8 DELIVERY 1 0.0015
9 ANTIBIOTIC THERAPY 1 0.0010
10 NASAL PRURITUS 1 0.0008
11 MAST CELL ACTIVATION SYNDROME 1 0.0007
12 PHARYNGEAL ERYTHEMA 1 0.0005
13 TYPE IV HYPERSENSITIVITY REACTION 1 0.0004
14 ANAPHYLACTOID REACTION 1 0.0002
15 POOR PERIPHERAL CIRCULATION 1 0.0002
16 THROAT TIGHTNESS 3 0.0001
17 PRODUCT PACKAGING ISSUE 1 0.0001
18 PHARYNGEAL SWELLING 1 0.0001
19 ANAPHYLACTIC REACTION 4 0.0001
20 SKIN REACTION 1 0.0001
21 PARAESTHESIA ORAL 1 0.0001
22 PHARYNGEAL OEDEMA 1 0.0001
23 FEELING HOT 3 0.0000
24 RASH GENERALISED 1 0.0000
25 MENTAL STATUS CHANGES 1 0.0000
26 URTICARIA 6 0.0000
27 WHEEZING 2 0.0000
28 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
29 EXPOSURE DURING PREGNANCY 2 0.0000
30 SWOLLEN TONGUE 1 0.0000
31 PRURITUS 12 0.0000
32 LIP SWELLING 1 0.0000
33 SKIN DISORDER 1 0.0000
34 EYE PRURITUS 1 0.0000
35 RASH ERYTHEMATOUS 1 0.0000
36 RASH PRURITIC 1 0.0000
37 LETHARGY 1 0.0000
38 ERYTHEMA 3 0.0000
39 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
40 PERIPHERAL SWELLING 2 0.0000
41 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
42 SWELLING 1 0.0000
43 DYSPHAGIA 1 0.0000
44 FLUSHING 1 0.0000
45 SINUSITIS 1 0.0000
46 HYPERSENSITIVITY 1 0.0000
47 RASH 2 0.0000
48 COUGH 1 0.0000
49 DYSPNOEA 2 0.0000
50 VOMITING 1 0.0000
51 NAUSEA 1 0.0000